You are here

Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

Last updated on May 10, 2018

FOR MORE INFORMATION
Study Location
Prairie Heart Institute
Springfield, Illinois, 62701 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Medication Non-Adherence
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
21+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male and female aged >21 years

- Have received a new or re-fil prescription for atorvastatin at first study visit to
Prairie Heart Institute

- Signed informed consent

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Unwilling to give written informed consent

- Failed statin treatment in the past

- Switched from another statin to atorvastatin because of co-pay program

- Participated in an earlier Market Research study on Impact of cholesterol management
behaviors post in-clinic adherence intervention

NCT01078285
Pfizer
Completed
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Medication Non-Adherence
NCT01078285
All Genders
21+
Years
Multiple Sites
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Impact Of An Integrated Intervention Program On Adherence To Atorvastatin
Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the seriousness of the disease, and fear of side effects. An intervention strategy comprising 3-5 minutes of counseling, emotional support and cost-sharing may be motivational and improve adherence to treatment.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
  • Male and female aged >21 years
  • Have received a new or re-fil prescription for atorvastatin at first study visit to Prairie Heart Institute
  • Signed informed consent
Medication Non-Adherence
  • Behavioral: No Patient Counseling
    Patients do not receive any adherence counseling, or other patient support services
  • Behavioral: Adherence Counseling
    Patients receive 3-5 minutes of adherence counseling, and other patient support services
  • Control
    Intervention: Behavioral: No Patient Counseling
  • Intervention Arm
    Intervention: Behavioral: Adherence Counseling
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
500
November 2011
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male and female aged >21 years
  • Have received a new or re-fil prescription for atorvastatin at first study visit to Prairie Heart Institute
  • Signed informed consent

Exclusion Criteria:

  • Unwilling to give written informed consent
  • Failed statin treatment in the past
  • Switched from another statin to atorvastatin because of co-pay program
  • Participated in an earlier Market Research study on Impact of cholesterol management behaviors post in-clinic adherence intervention
Sexes Eligible for Study: All
21 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01078285
A2581184
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
July 2015

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now